ANIK

ANIK

USD

Anika Therapeutics Inc. Common Stock

$9.630-0.040 (-0.414%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$9.670

High

$9.850

Low

$9.400

Volume

0.26M

Company Fundamentals

Market Cap

138.8M

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

Trading Stats

Avg Volume

0.10M

Exchange

NMS

Currency

USD

52-Week Range

Low $7.87Current $9.630High $18.37

Related News

Analyst Upgrades

Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $15 Price Target

Barrington Research analyst Michael Petusky maintains Anika Therapeutics with a Outperform and maintains $15 price target.

View more
Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $15 Price Target
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

View more
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

View more
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK